Europe has a complex biotech landscape, with hundreds of companies, multiple paths to innovation and financing, and marked differences among countries. To see through the complexity, we grouped approximately 1,000 European biotech companies into eight clusters based on country, modality, and therapeutic area. We identified biotech hot spots as well as trends and possible directions for the region. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
